Table of Contents Global Xerostomia (Dry Mouth) Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Market Overview 1.1 Xerostomia (Dry Mouth) Therapeutics Introduction 1.2 Market Analysis by Type 1.2.1 Salivary Stimulants 1.2.2 Salivary Substitutes 1.2.3 Dentifrices 1.3 Market Analysis by Applications 1.3.1 OTC 1.3.2 Prescription 1.4 New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics 1.5 Industry News Analysis of Xerostomia (Dry Mouth) Therapeutics 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics 2.2 Raw Material Analysis of Xerostomia (Dry Mouth) Therapeutics 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Xerostomia (Dry Mouth) Therapeutics 2.4 Other Costs Analysis of Xerostomia (Dry Mouth) Therapeutics 2.5 Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics 2.6 Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics 2.7 Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 2.8 Downstream Buyers of Xerostomia (Dry Mouth) Therapeutics 3 Global Xerostomia (Dry Mouth) Therapeutics Players Profiles and Sales Data 3.1 GlaxoSmithKline plc 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.1.2.1 Salivary Stimulants 3.1.2.2 Salivary Substitutes 3.1.2.3 Dentifrices 3.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 GlaxoSmithKline plc Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.2 Church & Dwight Co., Inc. 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.2.2.1 Salivary Stimulants 3.2.2.2 Salivary Substitutes 3.2.2.3 Dentifrices 3.2.3 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Church & Dwight Co., Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.3 Colgate-Palmolive Company 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.3.2.1 Salivary Stimulants 3.3.2.2 Salivary Substitutes 3.3.2.3 Dentifrices 3.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Colgate-Palmolive Company Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.4 Hikma Pharmaceuticals PLC 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.4.2.1 Salivary Stimulants 3.4.2.2 Salivary Substitutes 3.4.2.3 Dentifrices 3.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Hikma Pharmaceuticals PLC Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.5 Pendopharm 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.5.2.1 Salivary Stimulants 3.5.2.2 Salivary Substitutes 3.5.2.3 Dentifrices 3.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pendopharm Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.6 Sun Pharmaceuticals Industries Ltd. 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.6.2.1 Salivary Stimulants 3.6.2.2 Salivary Substitutes 3.6.2.3 Dentifrices 3.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sun Pharmaceuticals Industries Ltd. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.7 Lupin Pharmaceuticals, Inc. 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.7.2.1 Salivary Stimulants 3.7.2.2 Salivary Substitutes 3.7.2.3 Dentifrices 3.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Lupin Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.8 Pfizer, Inc. 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.8.2.1 Salivary Stimulants 3.8.2.2 Salivary Substitutes 3.8.2.3 Dentifrices 3.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Pfizer, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.9 Parnell Pharmaceuticals, Inc. 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.9.2.1 Salivary Stimulants 3.9.2.2 Salivary Substitutes 3.9.2.3 Dentifrices 3.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Parnell Pharmaceuticals, Inc. Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.10 Acacia Pharma 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Xerostomia (Dry Mouth) Therapeutics Product Category, Application and Specification 3.10.2.1 Salivary Stimulants 3.10.2.2 Salivary Substitutes 3.10.2.3 Dentifrices 3.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Acacia Pharma Different Types of Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Different Applications and Its Application Share 3.11 OraCoat 4 Global Xerostomia (Dry Mouth) Therapeutics Market Competition by Manufacturers 4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales and Share by Manufacturers (2012-2017) 4.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Market Concentration Rate 4.3.1 Top 3 Xerostomia (Dry Mouth) Therapeutics Manufacturer Market Share 4.3.2 Top 6 Xerostomia (Dry Mouth) Therapeutics Manufacturer Market Share 4.4 Market Competition Trend 5 Global Xerostomia (Dry Mouth) Therapeutics Market Analysis by Regions 5.1 Global Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Regions 5.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales by Regions (2012-2017) 5.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Regions (2012-2017) 5.2 North America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 5.3 Europe Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 5.4 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 5.5 South America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 5.6 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 6 North America Xerostomia (Dry Mouth) Therapeutics by Countries 6.1 North America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries 6.1.1 North America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 6.1.2 North America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) 6.2 United States Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 6.3 Canada Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 6.4 Mexico Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 7 Europe Xerostomia (Dry Mouth) Therapeutics by Countries 7.1 North America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries 7.1.1 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 7.1.2 Europe Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 7.2 Germany Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 7.3 France Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 7.4 UK Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 7.5 Russia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 7.6 Italy Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 8 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics by Countries 8.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 8.1.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 8.2 China Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 8.3 Japan Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 8.4 Korea Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 8.5 India Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 8.6 Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 9 South America Xerostomia (Dry Mouth) Therapeutics by Countries 9.1 South America Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries 9.1.1 South America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 9.1.2 South America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 9.2 Brazil Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 9.3 Argentina Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 9.4 Columbia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 10 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics by Countries 10.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 10.1.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) 10.2 Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 10.3 UAE Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 10.4 Egypt Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 10.5 Nigeria Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 10.6 South Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) 11 Global Xerostomia (Dry Mouth) Therapeutics Market Segment by Type 11.1 Global Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Market Share by Type (2012-2017) 11.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales and Market Share by Type (2012-2017) 11.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Market Share by Type (2012-2017) 11.2 Salivary Stimulants Sales Growth Rate and Price 11.2.1 Global Salivary Stimulants Sales Growth Rate (2012-2017) 11.2.2 Global Salivary Stimulants Price (2012-2017) 11.3 Salivary Substitutes Sales Growth Rate and Price 11.3.1 Global Salivary Substitutes Sales Growth Rate (2012-2017) 11.3.2 Global Salivary Substitutes Price (2012-2017) 11.4 Dentifrices Sales Growth Rate and Price 11.4.1 Global Dentifrices Sales Growth Rate (2012-2017) 11.4.2 Global Dentifrices Price (2012-2017) 11.5 Sales Growth Rate and Price 11.5.1 Global Sales Growth Rate (2012-2017) 11.5.2 Global Price (2012-2017) 11.6 Sales Growth Rate and Price 11.6.1 Global Sales Growth Rate (2012-2017) 11.6.2 Global Price (2012-2017) 12 Global Xerostomia (Dry Mouth) Therapeutics by Application 12.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Application (2012-2017) 12.2 OTC Sales Growth Rate (2012-2017) 12.3 Prescription Sales Growth Rate (2012-2017) 12.4 Sales Growth Rate (2012-2017) 12.5 Sales Growth Rate (2012-2017) 12.6 Sales Growth Rate (2012-2017) 13 Global Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) 13.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Price Forecast (2018-2023) 13.1.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume and Growth Rate Forecast (2018-2023) 13.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Global Xerostomia (Dry Mouth) Therapeutics Price and Trend Forecast (2018-2023) 13.2 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2023) 13.2.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2023) 13.2.3 Global Xerostomia (Dry Mouth) Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 North America (United States, Canada and Mexico) Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Europe (Germany, France, UK, Russia and Italy) Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 South America (Brazil, Argentina, Columbia) Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2023) 13.3 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2018-2023) 13.3.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue Forecast by Type (2018-2023) 13.3.3 Global Xerostomia (Dry Mouth) Therapeutics Price Forecast by Type (2018-2023) 13.4 Global Xerostomia (Dry Mouth) Therapeutics Sales Volume Forecast by Application (2018-2023) 13.4.1 Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2018-2023) 13.4.2 Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Application (2018-2023) 14 Sales Channel, Distributors, Traders and Dealers 14.1 Sales Channel 14.1.1 Direct Marketing 14.1.2 Indirect Marketing 14.1.3 Marketing Channel Future Trend 14.2 Distributors, Traders and Dealers 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.2 Analyst Introduction 16.3 Data Source

List of Tables and Figures Figure Xerostomia (Dry Mouth) Therapeutics Picture Table Product Specifications of Xerostomia (Dry Mouth) Therapeutics Figure Global Sales Market Share of Xerostomia (Dry Mouth) Therapeutics by Types in 2017 Table Xerostomia (Dry Mouth) Therapeutics Types for Major Manufacturers Figure Salivary Stimulants Picture Figure Salivary Substitutes Picture Figure Dentifrices Picture Figure Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Applications in 2017 Figure OTC Picture Figure Prescription Picture Figure New Project SWOT Analysis of Xerostomia (Dry Mouth) Therapeutics Table Industry News List of Xerostomia (Dry Mouth) Therapeutics Figure Industry Chain Structure of Xerostomia (Dry Mouth) Therapeutics Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Xerostomia (Dry Mouth) Therapeutics in 2017 Figure Manufacturing Process Analysis of Xerostomia (Dry Mouth) Therapeutics Table Raw Materials Sources of Xerostomia (Dry Mouth) Therapeutics Major Manufacturers in 2017 Table Major Buyers of Xerostomia (Dry Mouth) Therapeutics Table GlaxoSmithKline plc Basic Information List Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Church & Dwight Co., Inc. Basic Information List Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Church & Dwight Co., Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Colgate-Palmolive Company Basic Information List Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Hikma Pharmaceuticals PLC Basic Information List Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pendopharm Basic Information List Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Pendopharm Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pendopharm Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Basic Information List Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Lupin Pharmaceuticals, Inc. Basic Information List Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Pfizer, Inc. Basic Information List Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Parnell Pharmaceuticals, Inc. Basic Information List Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Acacia Pharma Basic Information List Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Growth Rate (2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales Global Market Share (%) (2012-2017) Figure Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Revenue Global Market Share (%) (2012-2017) Table Salivary Stimulants Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Salivary Substitutes Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Dentifrices Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in OTC and Its Application Share Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in Prescription and Its Application Share Table Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Volume in and Its Application Share Table Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturer (2016-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturer in 2016 Figure Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Manufacturer in 2017 Table Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturer (2016-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Manufacturer in 2016 Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Manufacturer in 2017 Figure Top 3 Xerostomia (Dry Mouth) Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Xerostomia (Dry Mouth) Therapeutics Manufacturer (Revenue) Market Share in 2017 Figure Global Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Sales by Regions (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Regions (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue by Regions (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2012 Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Regions in 2017 Figure North America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure South America Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table North America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) Table North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Figure North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries in 2012 Figure North America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries in 2017 Table North America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) Table North America Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries (2012-2017) Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2012 Figure North America Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2017 Figure United States Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Canada Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Mexico Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Europe Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2012 Table Europe Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2017 Figure Germany Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure UK Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure France Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Russia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Italy Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) Table Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries (2012-2017) Figure China Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Japan Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Korea Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure India Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Southeast Asia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure South America Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table South America Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) Table South America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Figure South America Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries in 2017 Table South America Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) Table South America Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries (2012-2017) Figure South America Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2017 Figure Brazil Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Argentina Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Columbia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue and Growth Rate (2012-2017) Table Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales by Countries (2012-2017) Table Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales Market Share by Countries in 2017 Table Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue by Countries (2012-2017) Table Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2012 Figure Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Revenue Market Share by Countries in 2017 Figure Saudi Arabia Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure UAE Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Egypt Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure Nigeria Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Figure South Africa Xerostomia (Dry Mouth) Therapeutics Sales and Growth Rate (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Type (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue by Type (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Type (2012-2017) Figure Global Salivary Stimulants Sales Growth Rate (2012-2017) Figure Global Salivary Stimulants Sales Price (2012-2018) Figure Global Salivary Stimulants Sales Growth Rate (2012-2017) Figure Global Salivary Substitutes Sales Price (2012-2018) Figure Global Dentifrices Sales Growth Rate (2012-2017) Figure Global Dentifrices Sales Price (2012-2018) Table Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2012-2017) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Application (2012-2017) Figure Global OTC Sales Growth Rate (2012-2017) Figure Global Prescription Sales Growth Rate (2012-2017) Figure Global Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Growth Rate (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Regions (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Regions (2018-2023) Figure North America Sales Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) Figure Europe Sales Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) Figure Asia-Pacific Sales Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) Figure South America Sales Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) Figure Middle East and Africa Sales Xerostomia (Dry Mouth) Therapeutics Market Forecast (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Type (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Type (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Sales Forecast by Application (2018-2023) Table Global Xerostomia (Dry Mouth) Therapeutics Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

GlaxoSmithKline plc Church & Dwight Co., Inc. Colgate-Palmolive Company Hikma Pharmaceuticals PLC Pendopharm Sun Pharmaceuticals Industries Ltd. Lupin Pharmaceuticals, Inc. Pfizer, Inc. Parnell Pharmaceuticals, Inc. Acacia Pharma OraCoat